Evaporation pond at a potash refinery
Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

BCI Minerals (ASX:BCI) has seen its share price rise by more than 8% today after it told investors the second phase of the Groundwater Monitoring and Management Plan (GMMP) had been approved by the Australian Department of Water and Environmental Regulation.

The plan relates to BCI’s Mardie Salt and Potash Project in the Pilbara; its second phase – resubmitted on January 15 – will focus on real-time data taken from the filling of ponds one to three at the project.

Validation of the GMMP has involved collaboration between BCI, DWER and the Commonwealth Department of Climate Change, Energy, the Environment and Water (DCCEEW), with this being the final step before the latter two departments approve filling of the remaining ponds and crystallisers.

BCI aims to have the first salt on ship by 2027’s second quarter, but even before that, managing director David Boshoff said he’s pleased the project is steaming ahead.

“BCI appreciates the continued support the Mardie Project has received from DWER and DCCEEW,” he said. “With construction progressing strongly, the company is excited and ready to commence filling the remaining ponds and crystallisers as soon as we receive DCCEEW’s approval.”

BCI shares last sold at 25.5c after rising 6.38% through Friday trade.

Join the discussion: See what HotCopper users are saying about BCI Minerals and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

bci by the numbers
More From The Market Online
The Market Online Video

Market Close: ASX 200 rallies as risk appetite returns, but business confidence weakens

The Australian sharemarket finished firmly higher today with the S&P/ASX 200 adding 106.50 points, or 1.18%, to close at 9,136.20.

EVE Health Group signs Australian compounding agreement for rapidly rising Men’s Health issue

EVE Health Group has signed an agreement with Optimal Pharmacy Plus Stafford aimed at the Australian…

Nanoveu’s EMASS signs DigiKey as Global Distributor for ECS-DoT-22

Nanoveu's wholly-owned subsidiary EMASS has signed DigiKey as its global distributor for ECS-DoT-22 system.
The Market Online Video

Wealth Within: Wall Street Tech Sinks While ASX Tech Soars

Wall Street’s technology stocks have been hammered, with the Nasdaq plunging 5.5 per cent in a single session and Nvidia falling more tha…